Tranzyme Pharma (TZYM) Announces First Quarter 2013 Financial Results
5/10/2013 9:28:11 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
RESEARCH TRIANGLE PARK, N.C., May 9, 2013 (GLOBE NEWSWIRE) -- Tranzyme Pharma (Nasdaq:TZYM) ("Tranzyme"), a biopharmaceutical company focused on discovering, developing and commercializing novel, mechanism-based therapeutics, today announced its financial results for the first quarter ended March 31, 2013.
Help employers find you! Check out all the jobs and post your resume.
comments powered by